JAMES A. GERAGHTY - 07 Aug 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role
Director
Signature
/s/ Thomas Bures
Issuer symbol
PVLA
Transactions as of
07 Aug 2024
Net transactions value
+$1
Form type
4
Filing time
28 Oct 2024, 17:18:29 UTC
Previous filing
18 Jun 2024
Next filing
12 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIRS Series F Preferred Stock, par value $0.001 per share Purchase $1 +1 $1.00* 1 07 Aug 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 7, 2024, the Reporting Person purchased one (1) share of Series F Preferred Stock, par value $0.001 per share (the "Preferred Stock"), of Pieris Pharmaceuticals, Inc. (the "Issuer") from the Issuer for cash consideration of $1.00. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series F Preferred Stock filed by the Issuer with the Nevada Secretary of State on August 7, 2024 (the "Series F COD"), including the right to have 25,000,000 votes and to vote together with the outstanding shares of the Issuer's common stock as a single class exclusively with respect to such voting proposals defined in the Series F COD.